Hemab Therapeutics Holdings, Inc. (COAG)

NASDAQ: COAG · Real-Time Price · USD

25.34

-8.66 (-25.47%)

At close: May 4, 2026, 4:00 PM EDT

25.00

-0.34 (-1.34%)

After-hours: May 4, 2026, 7:28 PM EDT

COAG Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-63.91	-48.71
Depreciation & Amortization	0.3	0.25
Loss (Gain) From Sale of Investments	-0.77	-1.28
Stock-Based Compensation	2.01	1.91
Other Operating Activities	-0.46	0.79
Change in Accounts Payable	2.58	0.91
Change in Other Net Operating Assets	-1.22	0.54
Operating Cash Flow	-61.48	-45.59
Capital Expenditures	-0.02	-0.28
Investment in Securities	-81.47	62.19
Investing Cash Flow	-81.48	61.9
Long-Term Debt Repaid	-0.12	-0.1
Net Debt Issued (Repaid)	-0.12	-0.1
Financing Cash Flow	156.3	-0.1
Foreign Exchange Rate Adjustments	0.22	-
Net Cash Flow	13.57	16.21
Free Cash Flow	-61.49	-45.87
Free Cash Flow Per Share	-1430.02	-1066.84
Cash Interest Paid	0.01	0.02
Cash Income Tax Paid	0.17	0.09
Levered Free Cash Flow	-39.67	-
Unlevered Free Cash Flow	-39.67	-
Change in Working Capital	1.36	1.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q